Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 12 January 2009, doi:10.1136/bmj.a3006
Cite this as: BMJ 2009;338:a3006
Despina G Contopoulos-Ioannidis, assistant professor1,2, Anastasia Karvouni, research fellow3, Ioanna Kouri, research fellow3, John P A Ioannidis, professor3,4
1 Department of Paediatrics, University of Ioannina School of Medicine, Ioannina, Greece, 2 Department of Paediatrics, George Washington University, School of Medicine and Health Sciences, Washington, DC, USA, 3 Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Greece, 4 Institute for Clinical Research and Health Policy Studies, Tufts University School of Medicine, Boston, MA, USA
Correspondence to: J P A Ioannidis, Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina 45110, Greece jioannid{at}cc.uoi.gr
Design Systematic review.
Data sources PubMed, contact with authors for missing information, and author survey for unpublished SF-36 data.
Study selection Randomised trials with SF-36 outcomes (the most extensively validated and used health survey instrument for appraising quality of life) that were published in 2005 in 22 journals with a high impact factor.
Data extraction Analyses on the two composite and eight subdomain SF-36 scores that corresponded to the time and mode of analysis of the primary efficacy outcome.
Results Of 1057 screened trials, 52 were identified as randomised trials with SF-36 results (66 separate comparisons). Only eight trials reported all 10 SF-36 scores in the published articles. For 21 of the 66 comparisons, SF-36 results were discordant for statistical significance compared with the results for primary efficacy outcomes. Of 17 statistically significant SF-36 scores where primary outcomes were not also statistically significant in the same direction, the magnitude of effect was small in six, moderate in six, large in three, and not reported in two. Authors modified the interpretation of study findings based on SF-36 results in only two of the 21 discordant cases. Among 100 additional randomly selected trials not reporting any SF-36 information, at least five had collected SF-36 data but only one had analysed it.
Conclusions SF-36 measurements sometimes produce different results from those of the primary efficacy outcomes but rarely modify the overall interpretation of randomised trials. Quality of life and health related survey information should be utilised more systematically in randomised trials.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?
Read all Rapid Responses